Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Cochrane Reviews,  Clinical Article

Walters JAE et al. – The authors based assessment of the efficacy of short compared to longer duration systemic corticosteroid therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD) in this review on four of the seven included studies for which data were available. The finding in this review that there is no significant increase in treatment failure with shorter systemic corticosteroid treatment for seven days or less for acute exacerbations of COPD, does not give conclusive evidence to recommend change in clinical practice due to a wide confidence interval around the estimate of effect.

Methods
  • The authors searched the Cochrane Airways Group Register of Trials (to April 2011) Cochrane Central Register of Controlled Trials (to April 2011), MEDLINE (from 1950 to October 2010), EMBASE (from 1980 to October 2010) and the reference lists of articles.
  • Randomised controlled trials comparing different durations of SC (seven days or fewer or more than seven days).
  • Other interventions, e.g. bronchodilators and antibiotics, were standardised; studies in other lung diseases were excluded, unless data on participants with COPD were available.
  • Two review authors independently extracted data that were pooled them using Review Manager 5.
  • The authors sought missing data from authors of studies published as abstracts only.

Results
  • The authors identified seven studies including 288 participants; two studies were fully published and five were published as abstracts.
  • The authors obtained data for two studies published as abstracts from authors; these two abstracts and the two full papers contributed to meta–analysis.
  • No study specified COPD diagnostic criteria and only one specified exacerbation criteria.
  • Short course treatment varied between three and seven days and longer duration 10 to 15 days, at equivalent daily doses of corticosteroids; five studies used oral prednisolone (dose 30 mg, four studies, one tapered dose) and two studies used intravenous corticosteroid treatment.
  • Mean ages of participants ranged from 64 to 73 years.
  • The authors assessed the risk of allocation and blinding bias as low for these studies.
  • Primary outcomes: risk of treatment failure did not differ significantly by treatment duration, but the confidence interval (CI) was too wide to conclude equivalence (odds ratio (OR) 0.94, 95% CI 0.38 to 2.36) (three studies, n = 158).
  • Forced expiratory volume in 1 second (FEV1) did not differ significantly when measured up to seven days (mean difference (MD) 0.07 L, 95% CI 0.19 to 0.05) or after seven days (MD 0.02 L, 95% CI 0.10 to 0.06) (four studies, n = 197).
  • The likelihood of an adverse event (four studies, n = 102) did not differ significantly by treatment duration, but again the CI was wide (OR 0.58, 95% CI 0.14 to 2.40).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Is non-invasive ventilation safe in acute severe asthma? Respirology, November 11, 2014    Review Article

3 Maternal vitamin D and E intakes during pregnancy are associated with asthma in children European Respiratory Journal , November 6, 2014    Clinical Article

4 Study shows possible link between asthma, cardiovascular disease University of Wisconsin-Madison News, November 20, 2014

5 Multicentric study on the beta-blocker use and relation with exacerbations in COPD Respiratory Medicine, June 19, 2014    Clinical Article

6 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

7 Efficacy of mycophenolate mofetil in sarcoidosis Respiratory Medicine, October 29, 2014    Review Article

8 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

9 Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD Full Text International Journal of COPD, November 24, 2014    Free full text    Clinical Article

10 Prophylactic antibiotic therapy after inhalation injury Burns, October 10, 2014    Clinical Article

11 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

12 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

13 Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years: National Health Interview Survey data 2004 to 2011 Journal of Occupational and Environmental Medicine, October 17, 2014    Clinical Article

14 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

15 A cytomorphometric analysis of pulmonary and mediastinal granulomas: Differentiating histoplasmosis from sarcoidosis by fine-needle aspiration Cancer Cytopathology, November 5, 2014    Review Article

16 Clinical phenotypes in sarcoidosis Current Opinion in Pulmonary Medicine, August 12, 2014    Review Article

17 Noninvasive ventilation with complex critical care ventilator in the treatment of acute exacerbation of chronic obstructive pulmonary disease The Journal of International Medical Research, August 12, 2014    Clinical Article

18 Endobronchial ultrasound-guided transbronchial biopsy and brushing: A comparative evaluation for the diagnosis of peripheral pulmonary lesions European Journal of Cardio-Thoracic Surgery, April 18, 2014    Review Article

19 Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen Respiratory Medicine, February 3, 2014    Clinical Article

20 Long-term outcomes after in-hospital CPR in older adults with chronic illness Chest, November 14, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore